Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DenQ Sub SLA Implant System

K-Number: K240977 · 2024-09-13

ApplicantDenq
Decision Date2024-09-13
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

DenQ Sub SLA Implant System is a medical device manufactured by Denq. It received FDA 510(k) clearance on 2024-09-13 under approval number K240977. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DenQ Sub SLA Implant System?

DenQ Sub SLA Implant System is a medical device that received FDA 510(k) clearance on 2024-09-13. It is manufactured by Denq. The 510(k) number is K240977.

When was DenQ Sub SLA Implant System approved by the FDA?

DenQ Sub SLA Implant System received FDA 510(k) clearance on 2024-09-13, under approval number K240977.

What company makes DenQ Sub SLA Implant System?

DenQ Sub SLA Implant System is manufactured by Denq.

What is the FDA product code for DenQ Sub SLA Implant System?

The FDA product code for DenQ Sub SLA Implant System is DZE.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: DZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.